Tagged with Flu

Flu Vaccination More Important Than Ever to Ensure Global Healthcare Systems Protect Most Vulnerable

Global Flu Vaccination More Important Than Ever to Ensure Global Healthcare Systems Protect Most Vulnerable

Global Paula Barbosa, head of influenza policy and advocacy at the IFPMA and board member of the #TogetherAgainstFlu campaign, looks ahead to what could be a devastating 2021/22 flu season, with natural immunity among vulnerable populations down following the pandemic induced lockdowns and preventive measures of last year. Barbosa lays out…

Jan de Backer – CEO, Fluidda

Belgium Jan de Backer – CEO, Fluidda

Belgium Fluidda is the world leader in the field of functional respiratory imaging which combines HRCT scans and computational fluid dynamics technology. CEO Jan de Backer outlines the major developments of the Belgian firm’s recent history including expansion into the US, how a USD ten million injection of Series A financing…

Interview: Salvador Lopez – General Manager, Mundipharma Portugal

Portugal Interview: Salvador Lopez – General Manager, Mundipharma Portugal

Portugal Salvador Lopez saw an opportunity in the summer of 2015 to create the first Portuguese affiliate for Mundipharma. Three years on, he reveals how their business model, company culture and leadership has succeeded in disrupting the respiratory market with their blockbuster drug Flutiform, built the fastest growing subsidiary in Portugal…

pharma Interview: Gauta Phillip Mavundla – General Manager, Established Pharmaceuticals Division, Abbott Laboratories S.A. (Pty) Ltd, South Africa

pharma The General Manager of Abbott’s Established Pharmaceuticals Division in South Africa, Gauta Phillip Mavundla illustrates how he is building the division’s presence within the region after the spinoff of AbbVie, while also highlighting branded generics as a key growth driver and how the company plans on expanding its capabilities in…

Pharma Interview: Jos Joore and Paul Vulto – Co-Founders, Mimetas, The Netherlands

Pharma OrganoPlates™ serve as a highly useable platform for 3D cell cultures, are completely compatible with existing lab equipment, and can be used to develop true ‘organ-on-a-chip’ models. Co-founders of the developer and manufacturer, Mimetas, discuss the impact this product is already having on the drug development process, and its potential…

FluidDA Interview with Jan De Backer, CEO, FluidDA

FluidDA Dr De Backer looking into your background, we see that you have a background in aerospace engineering and applied biomedical computational fluid dynamics that is riddled with awards for your innovative research. Given your commendable achievements, what would you say motivated you to found FluidDA in 2007? Over the course…